Major pharmacological distinction of the ACTH receptor from other melanocortin receptors

Life Sciences

Volumn 59, Issue 10, 1996, Pages 797-801

  Schiöth, Helgi B ^a,d   Chhajlani, Vijay ^a   Muceniece, Ruta ^b   Klusa, Vija ^b   Wikberg, Jarl E S ^a,c  

^a UPPSALA UNIVERSITY   (Sweden)

^b LATVIAN INSTITUTE OF ORGANIC SYNTHESIS   (Latvia)

^c Wa Pharm   (Sweden)

^d UPPSALA UNIVERSITY   (Sweden)

Author keywords

ACTH; Melanocortin receptor subtypes; Y1; 125I Nle4,D Phe7 MSH ligand binding

Indexed keywords

ALPHA INTERMEDIN; ALPHA INTERMEDIN[4 NORLEUCINE 7 DEXTRO PHENYLALANINE]; BETA INTERMEDIN; COMPLEMENTARY DNA; CORTICOTROPIN RECEPTOR; CORTICOTROPIN[1-39]; GAMMA 1 INTERMEDIN; IODINE 125; MELANOCORTIN PEPTIDE; MELANOCORTIN RECEPTOR; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

ADRENAL CORTEX CELL; ANIMAL CELL; ARTICLE; BINDING COMPETITION; CELL LINE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; DRUG SPECIFICITY; GENETIC TRANSFECTION; MOUSE; NONHUMAN; RECEPTOR AFFINITY;

ANIMALIA;

EID: 0030564894     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/0024-3205(96)00370-0     Document Type: Article

References (24)

1. 1. S. NAKANISHI, A. INOUE, T. KITA, M. NAKAMURA, A.C.Y. CHANG, S.M. COHEN, S. NUMA, Nature 278 423-427 (1979).
2. 2. P. PRUSIS, P-A. FRÄNDBERG, R. MUCENIECE, I. KALVINSH, J.E.S. WIKBERG, Biochem. Biophys. Res. Commun. 210 205-210 (1995).
3. 3. W. SIEGRIST, A.N. EBERLE, Trends Endocrinol. Metabol. 6 115-120 (1995).
4. 4. E.R. SIMPSON, M.R. WATERMAN, Ann. Rev. Physiol. 50 427-440 (1988).
5. 5. V. CHHAJLANI, J.E.S. WIKBERG, FEBS Lett. 309 417-420 (1992).
6. 6. K.G. MOUNTJOY, L.S. ROBBINS, M.T. MORTRUD, R.D. CONE, Science 257 1248-1251 (1992).
7. 7. I. GANTZ, Y. KONDA, T. TASHIRO, Y. SHIMOTO, H. MIWA, G. MUNZERT, S.J. WATSON, J. DEL VALLE, T. YAMADA, J. Biol. Chem. 268 8246-8250 (1993).
8. 8. I. GANTZ, H. MIWA, Y. KONDA, Y. SHIMOTO, T. TASHIRO, S.J. WATSON, V. DEL VALLE, T. YAMADA, J Biol Chem. 268 15174-15179 (1993).
9. 9. V. CHHAJLANI, R. MUCENIECE, J.E.S. WIKBERG, Biochem. Biophys. Res. Commun. 195 866-873 (1993).
10. 10. A. WEBER, S. KAPAS, J. HINSON, D.B. GRANT, A. GROSSMAN, A.J.L. CLARK, Biochem. Biopys. Res. Commun. 197 172-178 (1993).
11. 11. H.B. SCHIÖTH, R. MUCENIECE, J.E.S. WIKBERG, V. CHHAJLANI, Eur. J. Pharmacol., Mol. Pharm. Sect. 288 311-317 (1995).
12. 12. I. GANTZ, Y. SHIMOTO, Y. KONDA, H. MIWA, C.D. DICKINSON, T. YAMADA, Biochem. Biopys. Res. Commun. 200 1214-1220 (1994).
13. 13. R.J. LEFKOWITZ, J. ROTH, W. PRICER, I. PASTAN, Proc. Natl. Acad. Sci. USA. 65 745-752 (1970).
14. 14. J.B. TATRO, S. REICHLIN, Endocrinol. 121 1900-1907 (1987).
15. 15. Y.C. CHENG, W.H. PRUSOFF, Biochem. Pharmacol. 22 3099-3108 (1973).
16. 16. J. KOWAL, R. FIEDLER, Arch. Biochem. Biophys. 128 406-421 (1968).
17. 17. M. KUBO, T. ISHIZUKA, H. KIJIMA, M. KAKINUMA, T. KOIKE, Gene 153 279-280 (1995).
18. 18. K.G. MOUNTJOY, M.I. BIRD, W.E. RAINEY, R.D. CONE, Mol.Cell. Endocrinol. 99 R17-R20 (1994).
19. 19. M.-C. LEBRETHON, D. NAVILLE, M. BEGEOT, J. SAEZ, J. Clin. Invest. 93 1828-1833 (1994).
20. 20. P-A. FRÄNDBERG, R. MUCENIECE, P. PRUSIS, J.E.S. WIKBERG, V. CHHAJLANI, Biochem. Biophys. Res. Commun. 202 1266-1271 (1994).
21. 21. H.J. GOVERDE, G.J. PESMAN, A.G. SMALS, Biochem. Biophys. Res. Commun. 190 1060-1065 (1993).
22. 22. R. SCHWYZER, Ann NY Acad Sci. 297 3-26 (1977).
23. 23. K. HOFMANN, W. WINGENDER, F.M. FINN, Proc. Natl. Acad. Sci. USA. 67 829-836 (1970).
24. 24. D.J. BUCKLEY, J. RAMACHANDRAN, Proc. Natl. Acad. Sci. USA. 12 7431-7435 (1981).